# Study of Two Formulations of GSK Biologicals' Varicella Vaccine

> **NCT00568334** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 244 (actual)

## Conditions studied

- Varicella

## Interventions

- **BIOLOGICAL:** Varilrix (inactivated varicella vaccine)

## Key facts

- **NCT ID:** NCT00568334
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11-01
- **Primary completion:** 2008-03-18
- **Final completion:** 2008-04-29
- **Target enrollment:** 244 (ACTUAL)
- **Last updated:** 2018-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00568334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00568334, "Study of Two Formulations of GSK Biologicals' Varicella Vaccine". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00568334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*